Funding Announcements and Opportunities

Funding Announcements

Notice Notice of Intent to Publish a Funding Opportunity Announcement for a Data Coordinating Center for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
Notice Number NOT-DA-18-025
Estimated Application Due Date December 2018
Earliest Estimated Award Date February 2019
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Research Sites for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
Notice Number NOT-DA-18-026
Estimated Application Due Date December 2018
Earliest Estimated Award Date February 2019
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Centers for the Clinical Trials Network for Pain (CTNP) (U24 Clinical Trial Not Allowed)
Notice Number NOT-NS-18-069
Estimated Application Due Date September 14, 2018
Earliest Estimated Award Date December 4, 2018
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network for Pain - Data Coordinating Center (U24 Clinical Trial Not Allowed)
Notice Number NOT-NS-18-057
Estimated Application Due Date September 14, 2018
Earliest Estimated Award Date December 4, 2018
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network for Pain - Clinical Coordinating Center (U24 Clinical Trial Optional)
Notice Number NOT-NS-18-058
Estimated Application Due Date September 14, 2018
Earliest Estimated Award Date December 4, 2018

New Funding Opportunities

Project title NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
ID Number:  RFA-DA-18-020
Earliest Submission Date June 25, 2018
Application Due Date July 25, 2018; July 25, 2019, July 25, 2020), by 5:00 PM local time of applicant organization.
Project title Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
ID Number:  RFA-DA-19-002
Application Due Date Rolling basis beginning on January 25, 2018
Project title Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
ID Number:  RPAR-18-219
Application Due Date March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization
Project title Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
ID Number:  PAR-16-430
Application Due Date March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization.

Funded Projects

This page last reviewed on July 18, 2018